NPO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
EnPro Inc (NPO) does not present a compelling buy opportunity for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. While the technical indicators show bullish momentum, the lack of significant positive news, weak financial performance in the latest quarter, and neutral trading sentiment from hedge funds and insiders suggest a cautious approach. The stock's pre-market price of $288.78 is already near the upper resistance level (R1: $288.283), limiting immediate upside potential. Additionally, the absence of Intellectia Proprietary Trading Signals further reduces the attractiveness of this stock for immediate action.
The technical indicators suggest bullish momentum. The MACD is positive and expanding (1.836), and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). However, the RSI at 71.986 is in the neutral zone, indicating no clear overbought or oversold condition. The stock is trading near its resistance level (R1: $288.283), with limited room for immediate upward movement.
Analyst upgrades from Oppenheimer and KeyBanc, with price targets raised to $285 and $310, respectively, citing strong growth in AST cleaning solutions and Sealing segments. KeyBanc highlights the potential for sustained earnings momentum through 2026 due to investments in growth and M&A capabilities.
Weak financial performance in Q4 2025, with net income dropping to -$32M (-330.22% YoY) and EPS falling to -$1.51 (-328.79% YoY). Gross margin also declined slightly to 42.08%. Additionally, no recent news or significant trading activity from hedge funds, insiders, or Congress to support a strong buy case.
In Q4 2025, revenue increased by 14.32% YoY to $295.4M, driven by strength in AST cleaning solutions and Sealing segments. However, net income dropped significantly to -$32M, and EPS fell to -$1.51, reflecting poor profitability. Gross margin also declined slightly to 42.08%, indicating margin pressure.
Analysts are positive on EnPro, with Oppenheimer and KeyBanc raising price targets to $285 and $310, respectively, and maintaining Outperform/Overweight ratings. They highlight strong growth in key segments and a clear path to sustained earnings momentum through 2026.
